Elevation Oncology Inc. (ELEV) NASDAQ
$3.61 - (-)
Market Cap: $197.24M
As of 05/17/24 04:00 PM EDT. Market closed.
Elevation Oncology Inc. (ELEV)
NASDAQ
$3.61
- (-)
Market Cap: $197.24M
As of 05/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
elevation oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. we make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease. together with our peers we work towards a future in which each ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
34
Address
.
PRICE CHART FOR ELEVATION ONCOLOGY INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.61
Previous Close
$3.61
Days Range
$3.51 - $3.66
52 week range
$0.36 - $5.89
Volume
173,129
Avg. Volume (30 days)
753,327
Market Cap
$197.24M
Dividend Yield
-
P/E
-
Shares Outstanding
54,638,262
Open
$3.61
Previous Close
$3.61
Days Range
$3.51 - $3.66
52 week range
$0.36 - $5.89
Volume
173,129
Avg. Volume (30 days)
753,327
Market Cap
$197.24M
Dividend Yield
-
P/E
-
Shares Outstanding
54,638,262
FINANCIAL STATEMENTS FOR ELEVATION ONCOLOGY INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ELEVATION ONCOLOGY INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Furlong Tammy | CHIEF FINANCIAL OFFICER | May 15, 2024 | Option Exercise | $3.73 | 100 | 373 | 997 | May 17, 2024, 04:10 PM |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | Mar 16, 2024 | Option Exercise | $4.39 | 4,773 | 20,953 | 85,680 | Mar 19, 2024, 04:10 PM |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | Dec 16, 2023 | Option Exercise | $0.51 | 4,773 | 2,434 | 77,891 | Dec 19, 2023, 04:15 PM |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | Sep 16, 2023 | Option Exercise | $0.73 | 4,773 | 3,475 | 70,101 | Sep 19, 2023, 04:15 PM |
| Ferra Joseph J Jr | INTERIM CEO & CFO | Jun 16, 2023 | Option Exercise | $1.47 | 4,773 | 7,016 | 62,312 | Jun 21, 2023, 04:06 PM |
| Ferra Joseph J Jr | INTERIM CEO & CFO | Mar 16, 2023 | Option Exercise | $2.35 | 4,773 | 11,217 | 54,522 | Mar 20, 2023, 04:21 PM |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | Jun 16, 2022 | Option Exercise | $1.26 | 19,095 | 24,060 | 31,154 | Dec 19, 2022, 07:40 PM |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | Dec 16, 2022 | Option Exercise | $0.95 | 4,773 | 4,534 | 46,732 | Dec 19, 2022, 07:40 PM |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | Sep 16, 2022 | Option Exercise | $1.25 | 4,773 | 5,966 | 38,943 | Dec 19, 2022, 07:40 PM |
| venBio Global Strategic Fund III, L.P. | 10% Owner | May 25, 2022 | Sale | $4.12 | 702,737 | 2,897,806 | 1,905,430 | May 27, 2022, 07:20 PM |
| Qiming U.S. Healthcare Fund II, L.P. | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 312,500 | 5,000,000 | 2,370,142 | Jul 01, 2021, 07:45 PM |
| Aisling Capital IV, LP | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 187,500 | 3,000,000 | 2,834,910 | Jul 01, 2021, 06:29 PM |
| venBio Global Strategic Fund III, L.P. | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 625,000 | 10,000,000 | 2,608,167 | Jul 01, 2021, 05:27 PM |
| Cormorant Asset Management, LP | Former 10% Owner | Jun 29, 2021 | Buy | $16.00 | 250,000 | 4,000,000 | 2,233,168 | Jul 01, 2021, 04:24 PM |
| Vertex Global HC Fund II Pte. Ltd. | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 250,000 | 4,000,000 | 2,307,642 | Jun 29, 2021, 04:07 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Furlong Tammy | CHIEF FINANCIAL OFFICER | 05/15/2024 | 373 |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | 03/16/2024 | 20,953 |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | 12/16/2023 | 2,434 |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | 09/16/2023 | 3,475 |
| Ferra Joseph J Jr | INTERIM CEO & CFO | 06/16/2023 | 7,016 |
| Ferra Joseph J Jr | INTERIM CEO & CFO | 03/16/2023 | 11,217 |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | 06/16/2022 | 24,060 |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | 12/16/2022 | 4,534 |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | 09/16/2022 | 5,966 |
| venBio Global Strategic Fund III, L.P. | 10% Owner | 05/25/2022 | 2,897,806 |
| Qiming U.S. Healthcare Fund II, L.P. | 10% Owner | 06/29/2021 | 5,000,000 |
| Aisling Capital IV, LP | 10% Owner | 06/29/2021 | 3,000,000 |
| venBio Global Strategic Fund III, L.P. | 10% Owner | 06/29/2021 | 10,000,000 |
| Cormorant Asset Management, LP | Former 10% Owner | 06/29/2021 | 4,000,000 |
| Vertex Global HC Fund II Pte. Ltd. | 10% Owner | 06/29/2021 | 4,000,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ELEVATION ONCOLOGY INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 3,886,663 | 0.09% | New | Event Driven, Value |
| BALYASNY ASSET MANAGEMENT L.P. | 3,055,479 | 0.03% | New | Event Driven |
| ORBIMED ADVISORS LLC | 941,275 | 0.09% | -37.25% | Other |
| PALO ALTO INVESTORS LP | 1,346,666 | 0.78% | New | Other |
| RENAISSANCE TECHNOLOGIES LLC | 441,490 | 0.00037% | Exited | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 348,433 | 0.00017% | 51.4% | Other |
| BLACKROCK INC. | 171,901 | 0.00002% | 113.08% | Other |
BUYBACK ANNOUNCEMENT(S) FOR ELEVATION ONCOLOGY INC
LOADING...